Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Augmentation Study of LEvetiracetam in Obsessive Compulsive Disorder

NCT00299611 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00299611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00299611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Augmentation Study of LEvetiracetam in Obsessive Compulsive Disorder
Lead sponsor
Duke University
Phase
Phase 2/3
Overall status
Terminated
Start date
November 30, 2005
Completion date
April 30, 2008
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder